Kings Global Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.81 Cr
as on 16-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.32 Cr
as on 16-12-2024
- Satisfied Charges ₹ 4.81 Cr
as on 16-12-2024
- Revenue 38.73%
(FY 2022)
- Profit 10.09%
(FY 2022)
- Ebitda 24.41%
(FY 2022)
- Net Worth 15.99%
(FY 2022)
- Total Assets 143.71%
(FY 2022)
About Kings Global Biotech
The Corporate was formerly known as Kings Global Biotech Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.81 Cr.
The company currently has active open charges totaling ₹14.32 Cr. The company has closed loans amounting to ₹4.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Girish Jaiwal, Manodnya Sapre, and Kartiki Tupe serve as directors at the Company.
- CIN/LLPIN
U33119PN2016PLC164905
- Company No.
164905
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kings Global Biotech Limited offer?
Kings Global Biotech Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Anti Infective Agent, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Antibiotic Tablets, Capsule & Syrup, Anticoagulant and Antiplatelet Drugs.
Who are the key members and board of directors at Kings Global Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Jaiwal  | Director | 09-Jun-2016 | Current |
| Manodnya Sapre | Whole-Time Director | 14-Mar-2020 | Current |
| Kartiki Tupe | Additional Director | 28-Sep-2022 | Current |
Financial Performance of Kings Global Biotech.
Kings Global Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.73% increase. The company also saw a substantial improvement in profitability, with a 10.09% increase in profit. The company's net worth Soared by an impressive increase of 15.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kings Global Biotech?
In 2021, Kings Global Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skp Global Medicines Private LimitedActive 8 years 1 monthGirish Jaiwal, Manodnya Sapre and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 25 Mar 2021 | ₹14.32 Cr | Open |
The South Indian Bank Limited Creation Date: 26 Mar 2019 | ₹4.81 Cr | Satisfied |
How Many Employees Work at Kings Global Biotech?
Unlock and access historical data on people associated with Kings Global Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kings Global Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kings Global Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
